Up to $5M is available from GHFM Projects Grant Opportunity for researchers and multidisciplinary teams to work together to answer complex genomics research questions.

 

GHFM Projects Grant Opportunity

The Genomics Health Futures Mission (GHFM) Projects Grant Opportunity provides funding to support innovative and creative genomics research projects in the following areas: cancers (including lung cancer and mesothelioma) and diseases with high mortality and low survivability; paediatric acute care genomic research for clinically ill children; and ethical, legal and social issues related to genomics in health care.

 

Background

The Genomics Health Futures Mission (GHFM) is the centrepiece of the Australian Government’s $1.3 billion National Health and Medical Industry Growth Plan that was announced in May 2018. Funded through the MRFF, the GHFM will engage with communities to help save or transform the
lives of more than 200,000 Australians through research into better testing, diagnosis and treatment.

The objective of the GHFM is to deliver better diagnost cs and targeted treatments, avoid unnecessary health costs, and improve patient experience and outcomes. This will be achieved through partnership with state and territory governments, public and private entities in healthcare, and linkages with the National Health Genomics Policy Framework.

The Projects Grant stream, which forms part of the GHFM, will run over nine years from 2019-20 to 2027-28. Funding will be available for researchers at all career stages, including early and midcareer, and will encourage collaboration and multidisciplinary teams to work together to answer complex genomics research questions.

 

Objectives

The objectives of this grant opportunity are to:

  • fund innovative and creative genomics research projects in the following research areas:
    • cancers (including lung cancer and mesothelioma) and diseases with high mortality and low survivability
    • paediatric acute care genomic research for critically ill children
    • ethical, legal and social issues related to genomics in health care.
  • support collaboration of multidisciplinary research into genomics that prioritises health system and commercial needs.

 

Funding

Projects Grant stream

  • Cancers (including lung cancer and mesothelioma) and diseases with high mortality and low survivability rate research projects
    The total funding available for cancers and diseases (including lung cancer and mesothelioma) with high mortality and low survivability rate research projects is $15 million over three years. The grant amount will be up to 100 per cent of eligible project costs.
  • The minimum grant amount is $0.5 million
  • The maximum grant amount is $5 million.
  • Paediatric acute care genomic research for critically ill children projects
    The total funding available for paediatric acute care genomic research for critically ill children projects is $15 million over three years. The grant amount will be up to 100 per cent of eligible project costs.
  • The minimum grant amount is $0.5 million
  • The maximum grant amount is $5 million.

Ethical, Legal and Social Issues Research Grant stream

The total funding available for Ethical, legal and social issues related to genomics in health care projects is $3.7 million over three years. The grant amount will be up to 100 percent of eligible project costs.

  • The minimum grant amount is $ 0.1 million
  • The maximum grant amount is $0.5 million.

The maximum project period is three years.

 

Eligible Projects

To be eligible your project must:

  • be aimed at the purpose of the grant opportunity as outlined in section 4 and 3.2 of the Guidelines
  • include eligible expenditure
  • include one or more of the following eligible activities:
    • research and development
    • disease modelling
    • pre-clinical testing
    • clinical trials.

You must complete your project by 30 June 2022. Any further extension to project period will be subject to the availability of program funds.

 

Eligible Applicants

To be an eligible organisation you must:

  • have an Australian Business Number (ABN)
  • be incorporated in Australia,

and, in accordance with s24 of the Medical Research Future Fund Act 20153 , you must be one of the following eligible bodies:

  • a medical research institute
  • a university
  • a corporate Commonwealth entity
  • a corporation (including businesses and not for profits).

Joint applications are encouraged. You must have a lead applicant who is the main driver of the project and is eligible to apply. For further information on joint applications, refer to section 9.2 of the Guidelines

GHFM can only accept applications where you provide:

  • evidence from your board (or chief executive officer or equivalent if there is no board) that it supports the project and that you can complete the project and meet the costs of the project not covered by grant funding
  • a project plan, including risk management plan
  • a detailed project budget
  • an intellectual property plan
  • a data management plan.

Eligibility criteria cannot be waived under any circumstances.

 

Timing

Applications close 21 June 2019.

 

More Information